<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0019236"><a href="http://purl.obolibrary.org/obo/MONDO_0019236">MONDO:0019236</a></h3>
<p><strong>Label:</strong> disorder of purine metabolism</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0018106">MONDO:0018106</a> (hereditary xanthinuria), <a href="http://purl.obolibrary.org/obo/MONDO_0015253">MONDO:0015253</a> (Diamond-Blackfan anemia), <a href="http://purl.obolibrary.org/obo/MONDO_0016088">MONDO:0016088</a> (hypoxanthine-guanine phosphoribosyltransferase deficiency), <a href="http://purl.obolibrary.org/obo/MONDO_0010298">MONDO:0010298</a> (Lesch-Nyhan syndrome), <a href="http://purl.obolibrary.org/obo/MONDO_0010395">MONDO:0010395</a> (phosphoribosylpyrophosphate synthetase superactivity), <a href="http://purl.obolibrary.org/obo/MONDO_0013028">MONDO:0013028</a> (adenosine monophosphate deaminase deficiency), <a href="http://purl.obolibrary.org/obo/MONDO_0010699">MONDO:0010699</a> (Charcot-Marie-tooth disease X-linked recessive 5),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_45">Orphanet:45</a>, <a href="http://www.orpha.net/ORDO/Orphanet_124">Orphanet:124</a>, <a href="http://www.orpha.net/ORDO/Orphanet_99014">Orphanet:99014</a>, <a href="http://purl.obolibrary.org/obo/OMIM_300661">OMIM:300661</a>, <a href="http://purl.obolibrary.org/obo/OMIM_308950">OMIM:308950</a>, <a href="http://purl.obolibrary.org/obo/OMIM_300322">OMIM:300322</a>, <a href="http://purl.obolibrary.org/obo/OMIM_311070">OMIM:311070</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615511">OMIM:615511</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612874">OMIM:612874</a>, <a href="http://www.orpha.net/ORDO/Orphanet_3222">Orphanet:3222</a>, <a href="http://purl.obolibrary.org/obo/OMIM_278300">OMIM:278300</a>, <a href="http://www.orpha.net/ORDO/Orphanet_206428">Orphanet:206428</a>, <a href="http://www.orpha.net/ORDO/Orphanet_510">Orphanet:510</a>, <a href="http://www.orpha.net/ORDO/Orphanet_3467">Orphanet:3467</a>, <a href="http://purl.obolibrary.org/obo/OMIM_603592">OMIM:603592</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0004368">HP:0004368</a> (Increased purine levels) and <a href="http://purl.obolibrary.org/obo/HP_0011442">HP:0011442</a> (Abnormality of central motor function) 63.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002149">HP:0002149</a> (Hyperuricemia) and <a href="http://purl.obolibrary.org/obo/HP_0011442">HP:0011442</a> (Abnormality of central motor function) 63.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004368">HP:0004368</a> (Increased purine levels) and <a href="http://purl.obolibrary.org/obo/HP_0011804">HP:0011804</a> (Abnormality of muscle physiology) and <a href="http://purl.obolibrary.org/obo/HP_0012759">HP:0012759</a> (Neurodevelopmental abnormality) 63.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004368">HP:0004368</a> (Increased purine levels) and <a href="http://purl.obolibrary.org/obo/HP_0011442">HP:0011442</a> (Abnormality of central motor function) and <a href="http://purl.obolibrary.org/obo/HP_0012759">HP:0012759</a> (Neurodevelopmental abnormality) 63.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004368">HP:0004368</a> (Increased purine levels) and <a href="http://purl.obolibrary.org/obo/HP_0011442">HP:0011442</a> (Abnormality of central motor function) and <a href="http://purl.obolibrary.org/obo/HP_0011804">HP:0011804</a> (Abnormality of muscle physiology) 63.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003808">HP:0003808</a> (Abnormal muscle tone) and <a href="http://purl.obolibrary.org/obo/HP_0004368">HP:0004368</a> (Increased purine levels) and <a href="http://purl.obolibrary.org/obo/HP_0012759">HP:0012759</a> (Neurodevelopmental abnormality) 63.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003808">HP:0003808</a> (Abnormal muscle tone) and <a href="http://purl.obolibrary.org/obo/HP_0004368">HP:0004368</a> (Increased purine levels) and <a href="http://purl.obolibrary.org/obo/HP_0011442">HP:0011442</a> (Abnormality of central motor function) 63.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003011">HP:0003011</a> (Abnormality of the musculature) and <a href="http://purl.obolibrary.org/obo/HP_0004368">HP:0004368</a> (Increased purine levels) and <a href="http://purl.obolibrary.org/obo/HP_0012759">HP:0012759</a> (Neurodevelopmental abnormality) 63.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002149">HP:0002149</a> (Hyperuricemia) and <a href="http://purl.obolibrary.org/obo/HP_0011804">HP:0011804</a> (Abnormality of muscle physiology) and <a href="http://purl.obolibrary.org/obo/HP_0012759">HP:0012759</a> (Neurodevelopmental abnormality) 63.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002149">HP:0002149</a> (Hyperuricemia) and <a href="http://purl.obolibrary.org/obo/HP_0011442">HP:0011442</a> (Abnormality of central motor function) and <a href="http://purl.obolibrary.org/obo/HP_0012759">HP:0012759</a> (Neurodevelopmental abnormality) 63.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002149">HP:0002149</a> (Hyperuricemia) and <a href="http://purl.obolibrary.org/obo/HP_0011442">HP:0011442</a> (Abnormality of central motor function) and <a href="http://purl.obolibrary.org/obo/HP_0011804">HP:0011804</a> (Abnormality of muscle physiology) 63.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002149">HP:0002149</a> (Hyperuricemia) and <a href="http://purl.obolibrary.org/obo/HP_0003808">HP:0003808</a> (Abnormal muscle tone) and <a href="http://purl.obolibrary.org/obo/HP_0012759">HP:0012759</a> (Neurodevelopmental abnormality) 63.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002149">HP:0002149</a> (Hyperuricemia) and <a href="http://purl.obolibrary.org/obo/HP_0003808">HP:0003808</a> (Abnormal muscle tone) and <a href="http://purl.obolibrary.org/obo/HP_0011442">HP:0011442</a> (Abnormality of central motor function) 63.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002149">HP:0002149</a> (Hyperuricemia) and <a href="http://purl.obolibrary.org/obo/HP_0003011">HP:0003011</a> (Abnormality of the musculature) and <a href="http://purl.obolibrary.org/obo/HP_0012759">HP:0012759</a> (Neurodevelopmental abnormality) 63.33%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001249">HP:0001249</a> (Intellectual disability) and <a href="http://purl.obolibrary.org/obo/HP_0004368">HP:0004368</a> (Increased purine levels) and <a href="http://purl.obolibrary.org/obo/HP_0011804">HP:0011804</a> (Abnormality of muscle physiology) 63.33%</li>
</ul>
</body>
</html>
